U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.1955T>C (p.Met652Thr) AND Familial hypercholesterolemia

Germline classification:
Conflicting interpretations of pathogenicity (3 submissions)
Last evaluated:
Jan 28, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000775082.15

Allele description [Variation Report for NM_000527.5(LDLR):c.1955T>C (p.Met652Thr)]

NM_000527.5(LDLR):c.1955T>C (p.Met652Thr)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.1955T>C (p.Met652Thr)
Other names:
NM_000527.5(LDLR):c.1955T>C
HGVS:
  • NC_000019.10:g.11120201T>C
  • NG_009060.1:g.35821T>C
  • NM_000527.5:c.1955T>CMANE SELECT
  • NM_001195798.2:c.1955T>C
  • NM_001195799.2:c.1832T>C
  • NM_001195800.2:c.1451T>C
  • NM_001195803.2:c.1574T>C
  • NP_000518.1:p.Met652Thr
  • NP_000518.1:p.Met652Thr
  • NP_001182727.1:p.Met652Thr
  • NP_001182728.1:p.Met611Thr
  • NP_001182729.1:p.Met484Thr
  • NP_001182732.1:p.Met525Thr
  • LRG_274t1:c.1955T>C
  • LRG_274:g.35821T>C
  • LRG_274p1:p.Met652Thr
  • NC_000019.9:g.11230877T>C
  • NM_000527.4:c.1955T>C
  • c.1955T>C
Protein change:
M484T
Links:
LDLR-LOVD, British Heart Foundation: LDLR_000266; dbSNP: rs875989936
NCBI 1000 Genomes Browser:
rs875989936
Molecular consequence:
  • NM_000527.5:c.1955T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.1955T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.1832T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.1451T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.1574T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial hypercholesterolemia (FH)
Identifiers:
MONDO: MONDO:0005439; MedGen: C0020445; OMIM: PS143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000627024Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 28, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV000909186Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Mar 26, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001482447Laboratory of Molecular Genetics, National Medical Research Center for Therapy and Preventive Medicine
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significancegermlineresearch

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot provided1not providedresearch
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular spectrum of autosomal dominant hypercholesterolemia in France.

Marduel M, Carrié A, Sassolas A, Devillers M, Carreau V, Di Filippo M, Erlich D, Abifadel M, Marques-Pinheiro A, Munnich A, Junien C; French ADH Research Network., Boileau C, Varret M, Rabès JP.

Hum Mutat. 2010 Nov;31(11):E1811-24. doi: 10.1002/humu.21348.

PubMed [citation]
PMID:
20809525
PMCID:
PMC3152176

Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia.

Defesche JC, Stefanutti C, Langslet G, Hopkins PN, Seiz W, Baccara-Dinet MT, Hamon SC, Banerjee P, Kastelein JJP.

J Clin Lipidol. 2017 Nov - Dec;11(6):1338-1346.e7. doi: 10.1016/j.jacl.2017.08.016. Epub 2017 Sep 4. Erratum in: J Clin Lipidol. 2020 Sep - Oct;14(5):742. doi: 10.1016/j.jacl.2020.09.010.

PubMed [citation]
PMID:
28964736
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV000627024.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 652 of the LDLR protein (p.Met652Thr). This variant is present in population databases (no rsID available, gnomAD 0.006%). This missense change has been observed in individuals with familial hypercholesterolemia (PMID: 20809525, 28964736; Invitae). ClinVar contains an entry for this variant (Variation ID: 226382). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LDLR protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV000909186.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This missense variant (also known as p.Met631Thr in the mature protein) replaces methionine with threonine at codon 652 of the LDLR protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in several individuals affected with familial hypercholesterolemia (PMID: 20236128, 20809525, 22883975, 28964736). It has been shown that this variant segregates with disease in one family (Al-Olabi et al 2019). This variant has been identified in 1/251458 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Laboratory of Molecular Genetics, National Medical Research Center for Therapy and Preventive Medicine, SCV001482447.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedresearch PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

Last Updated: Aug 11, 2024